Skip to main content

Table 1 Clinical at-risk groups recommended to receive the annual influenza vaccination, 2020–2021 season [12]

From: Influenza vaccine uptake among at-risk adults (aged 16–64 years) in the UK: a retrospective database analysis

At-risk group
• Individuals aged from 6 months to less than 65 years of age, in a clinical risk group such as those with:
 • Chronic (long-term) respiratory disease, such as severe asthma, chronic obstructive pulmonary disease or bronchitis
 • Chronic heart disease, such as heart failure
 • Chronic kidney disease at stage three, four or five
 • Chronic liver disease
 • Chronic neurological disease, such as Parkinson’s disease or motor neurone disease
 • Learning disability
 • Diabetes
 • Splenic dysfunction or asplenia
 • A weakened immune system due to disease (such as HIV/AIDS) or treatment (such as cancer treatment)
 • Morbidly obese (defined as body-mass index ≥40 kg/m2)
• Pregnancy